This inventor holds 1 USPTO granted patent. Top assignee: Osaka University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Cesar Aguirre Martinez in Neurodegenerative Disease Diagnosis.
Introduction
Cesar Aguirre Martinez is an accomplished inventor based in Osaka, Japan. He has made significant contributions to the field of neurodegenerative disease diagnosis, particularly in differentiating between Parkinson's disease and multiple system atrophy. His innovative approach has the potential to improve diagnostic accuracy and patient outcomes.
Latest Patents
Cesar Aguirre Martinez holds a patent for a method and kit designed to discriminate between Parkinson's disease and multiple system atrophy. The patent outlines a systematic approach that includes preparing a solution containing α-synuclein monomers, adding a biological sample from a subject, allowing the monomers to aggregate, and detecting the resulting α-synuclein aggregates. This method represents a significant advancement in the diagnostic process for these complex conditions.
Career Highlights
Cesar Aguirre Martinez is affiliated with Osaka University, where he conducts research and develops innovative diagnostic methods. His work has garnered attention for its potential to enhance the understanding and treatment of neurodegenerative diseases. With a focus on practical applications, he aims to bridge the gap between research and clinical practice.
Collaborations
Cesar has collaborated with notable colleagues, including Hideki Mochizuki and Keita Kakuda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing the field of neurodegenerative disease research.
Conclusion
Cesar Aguirre Martinez's contributions to the diagnosis of neurodegenerative diseases highlight the importance of innovation in medical research. His patented method offers a promising avenue for improving diagnostic accuracy and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
